| Genetics is of the essence to face NAFLD M Meroni, M Longo, G Tria, P Dongiovanni Biomedicines 9 (10), 1359, 2021 | 38 | 2021 |
| Expanding phenotypic spectrum of mitochondrial abnormalities in patients with NAFLD and hypertriglyceridemia M Meroni, M Longo, E Paolini, G Tria, M Ripolone, L Napoli, M Moggio, ... Frontiers in Nutrition, 1870, 0 | 6* | |
| Recreating gut-liver axis during NAFLD onset by using a Caco-2/HepG2 co-culture system M Meroni, E Paolini, M Longo, R Piciotti, G Tria, S Fargion, ... OAE Publishing 2, 1-14, 2022 | 2 | 2022 |
| The different modulation of KLB expression impacts on liver damage in NAFLD patients and in an in vitro model: a novel druggable target? M Meroni, N Panera, G Tria, R Piciotti, M Longo, E Paolini, A Mosca, ... Journal of Hepatology 77, S706, 2022 | | 2022 |
| The overexpression of TM6SF2 and/or MBOAT7 wild-type genes re-establishes the mitochondrial dynamics in an in vitro NAFLD model. E Paolini, M Longo, M Meroni, G Tria, C Macchi, R Piciotti, A Agresta, ... Journal of Hepatology 77, S698-S699, 2022 | | 2022 |
| Modeling KLB deficiency by genome editing in hepatocytes: from oxidative stress and inflammation towards enhanced proliferation M Meroni, N Panera, R Piciotti, M Longo, E Paolini, G Tria, A Crudele, ... Digestive and Liver Disease 54, S50, 2022 | | 2022 |
